APA’s 2004 annual meeting will include a special research-based program track presented in collaboration with the National Institute on Drug Abuse, titled “Integrating the Science of Addiction Into Psychiatric Practice.” This special track will raise awareness of new and emerging issues in addiction and psychiatry and provide important information related to best practices and treatment strategies. More information on the series is available by contacting Beatrice Eld Edner at (703) 907-8598 or
[email protected].
Monday, May 3
9 a.m.-10:30 a.m.
Lecture 2
Signal Integration in the Brain
Paul Greengard, Ph.D.
Javits Center, Level 1, Rooms 1E07/8
Issue Workshop 6
Drug Abuse and Suicidal Behavior
Chair: Eric D. Caine, M.D.
Javits Center, Level 3, Room 3D02/11
Issue Workshop 16
Cocaine and Tobacco Use During Pregnancy: Adverse Outcomes in Offspring
Chair: Vincent L. Smeriglio, Ph.D.
Marriott Marquis, Seventh Floor, Empire/Hudson Rooms
11 a.m.-12:30 p.m.
Issue Workshop 26
Obtaining Research Funding From NIH: Keys to Successful Grant Writing
Chair: Lucinda L. Miner, Ph.D.
Marriott Marquis, Seventh Floor, Empire/Hudson Rooms
2 p.m.-5 p.m.
Symposium 3
Functional Brain Imaging of Addiction
Chair: Elliot A. Stein, Ph.D.
Javits Center, Level 1, Room 1E09
• Neuropsychiatric Implications of Mapping Reward/Aversion Circuitry
• Endogenous Opioid Neurotransmissions: Interfacing Reward and Stress Regulation
• Chronic Effects of Drug Use and HIV
• Neurobiological Substrates of Stimulant Action and Reward
Symposium 4
Treatment of Chronic Pain in Recovering Addicts
Chair: Jag Khalsa, Ph.D.
Javits Center, Level 1, Room 1E11
• Pain Assessment and Issues in Screening
• Assessing Aberrant Drug-Taking Behaviors in Medically Ill Patients With Pain
• The Development and Treatment of Opioid-Induced Hyperalgesia
• Prescribing Pain Medications for Recovering Addicts With Chronic Pain
• Principles of Pain Treatment in Addictive Disorders
Symposium 22
Obesity: Lessons Learned From Addiction
Chair: Joseph Frascella, Ph.D.
Discussant: Nora D. Volkow, M.D.
Marriott Marquis, Seventh Floor, Empire/Hudson Rooms
• Genetic, Motivational, and Metabolic Factors Modulate the Neural Drive to Maintain Body Weight
• Cortico-Striatal-Hypothalamic Networks and Motivation for Food: Integration of Cognition, Reward, and Energy
• Food and Drug Cravings: Metaphor or Common Mechanism?
• Common and Diverging Neurobiological Features of Feeding and Drug Self-Administration in Humans
• Obesity and Addiction: Neuroimaging Studies
Symposium 24
Genetic and Environmental Factors Contributing to Vulnerability to Addiction
Chair: Jonathan D. Pollock, Ph.D.
Marriott Marquis, Ninth Floor, Cantor/Jolson Rooms
• Using Twin Data to Identify Alternative Drug-Abuse Phenotypes
• Common and Specific Genetic Factors in the Development of Substance Dependence
• Addiction Molecular Genetics: Remarkably Converging Results
• Using the Systems Biology of Motivation for Genetic Studies in Psychiatry
• Genetic and Environmental Factors Modulate Cocaine Abuse in Monkey Models
Tuesday, May 4
9 a.m.-10:30 a.m.
Distinguished Psychiatrist Lecture 13
Why Does the Human Brain Become Addicted?
Nora D. Volkow, M.D.
Javits Center, Level 1, Room 1E15
Issue Workshop 45
Steroid Abuse: Growing Problem for Adolescents and a Hidden Problem for Adults
Chair: Donald R. Vereen, Jr, M.D.
Marriott Marquis, Fifth Floor, Alvin/Carnegie Rooms
Issue Workshop 48
Emerging Pharmacotherapies for Treatment of Stimulant Dependence
Chair: Francis J. Vocci, Ph.D.
Marriott Marquis, Fifth Floor, Imperial/Julliard Rooms
Issue Workshop 56
Addiction Research as a Career Choice in Psychiatry
Chairperson: Ivan D. Montoya, M.D.
Marriott Marquis, Seventh Floor, Herald/Soho Rooms
9 a.m.-11 a.m.
Research Advances in Medicine
The Epidemiology and Treatment of Psychiatric Comorbidities
Chair: Geetha Jayaram, M.D.
Co-Chair: Joel J. Wallack, M.D.
Javits Center, Level 1, Room 1E09
• Epidemiology of Comorbid Psychiatric and Addictive Disorders
• Comorbidity of Psychiatric and Addictive Disorders in Children
• Depression in Hepatitis C Patients and Interferon Treatment
• Research Advances in HIV Care
11 a.m.-12:30 p.m.
Frontiers of Science Lecture 15
Anticraving Medication: New Class of Psychoactive Medication?
Charles P. O'Brien, M.D.
Javits Center, Level 1, Room 1E15
Issue Workshop 74
Drugs and Other Addictions: Does One Size Fit All?
Chair: Steven J. Grant, Ph.D.
Marriott Marquis, Seventh Floor, Herald/Soho Rooms
Issue Workshop 75
Stress, Trauma, and Drug Abuse
Chair: Nancy Pilotte, Ph.D.
Marriott Marquis, Ninth Floor, Marquis Ballroom Salons A/B
2 p.m.-3:30 p.m.
Frontiers of Science Lecture 18
Conceptual and Methodological Flaws in the Evaluation of Addiction Treatment
A. Thomas McLellan, Ph.D.
Hilton New York, Third Floor, Trianon Ballroom
2 p.m.-5 p.m.
Symposium 42
Smoking and Comorbid Mental Disorders
Chair: John R. Hughes, M.D.
Javits Center, Level 3, Rooms 3D06/7
• Psychiatric Comorbidity of Smoking and Nicotine Dependence: An Epidemiologic Perspective
• The Neurobiology of Nicotine Dependence and Comorbid Psychiatric Disorders
• Nicotine-Dependence Treatment in Individuals With Schizophrenia
• Behavioral and Pharmacological Treatments for Smokers With Depression
Symposium 55
ADHD Subtypes and Subgroups at Risk for Substance Use Disorders
Chair: Naimah Z. Weinberg, M.D.
Marriott Marquis, Seventh Floor, Herald/Soho Rooms
• Subtypes of ADHD Youth At Risk for Substance Abuse
• Childhood ADHD, Comorbidity, and Risk for Late-Adolescent Drug Abuse
• Developmental Twin Studies of Relations Between Substance Use and ADHD
• Variability in Risk for Substance Use and Disorder Among Children Diagnosed With ADHD
• Behavioral and Cognitive Predictors of Adolescent Substance Use in Children With ADHD
• Long-Term Follow-Up of Childhood ADHD: Development of Adult Substance Abuse
Wednesday, May 5
9 a.m.-10:30 a.m.
Issue Workshop 82
Treatment of Patients With Drug Dependence and Psychiatric Illness
Co-Chair: Roger D. Weiss, M.D.
Co-Chair: Wilson Compton III, M.D.
Javits Center, Level 1, Room 1E12
11 a.m.-12:30 p.m.
Distinguished Psychiatrist Lecture 21
Stress and Relapse to Substance Use Disorders
Kathleen T. Brady, M.D.
Javits Center, Level 1, Rooms 1E07/8
2 p.m.-5 p.m.
Symposium 80
Consequences and Treatment of Marijuana Abuse
Chair: Susan R.B. Weiss, Ph.D.
Co-Chair: Jag Khalsa, Ph.D.
Marriott Marquis, Fifth Floor, Imperial/Julliard Rooms
• Cognitive Toxicity of Cannabis: The Devil Is in the Confounding Variables
• Cognitive Effects in Adolescents Exposed Prenatally to Marijuana or Cigarettes
• Effects of Chronic Marijuana Use and THC on Brain Function in Humans: A fMRI Study
• Behavioral and Treatment Research on Marijuana Withdrawal and Dependence
• The Endogenous Cannabinoids and the Control of Drug Craving
Symposium 84
Moving the Targets: The Neurobiology of Addiction
Chair: Nancy Pilotte, Ph.D.
Marriott Marquis, Seventh Floor, Columbia/Duffy Rooms
• Neuroadaptation in Addiction: The Extended Amygdala and Brain-Reward System
• Neural Circuitry of Relapse
• Drugs, Neuroplasticity, and Addiction
• How Do Drugs of Abuse Rewire the Motivational Circuitry?
Symposium 85
Drug Abuse Treatment Issues in Women
Chair: Cora Lee Wetherington, Ph.D.
Marriott Marquis, Seventh Floor, Empire/Hudson Rooms
• Gender Differences in Treatment Needs, Services, Utilization, and Outcomes
• Treatment Issues in Drug-Dependent Women With Comorbid Depression
• Trauma and PTSD: Issues in the Treatment of Drug-Dependent Women
• Drug-Dependent Women With Partner Violence: Treatment Issues
• Drug-Treatment Issues in Drug-Dependent, Pregnant Women
Thursday, May 6
2 p.m.-5 p.m.
Symposium 96
Behavioral Treatments for Drug Dependence
Chair: Lisa S. Onken, Ph.D.
Co-Chair: Bruce J. Rounsaville, M.D.
Javits Center, Level 1, Room 1E13
• Durability of Cognitive-Behavioral Therapy Efficacy for Substance Abusers
• HIV Risk Reduction and Substance Abuse Treatment
• Low-Cost Contingency Management in Community Settings
• Cognitive-Behavioral Therapy and Naltrexone for Cocaine Dependence
• Behavioral Family Counseling and Naltrexone for Male, Opioid-Dependent Patients